Assignee
NONO INC
CA·20 granted patents·13 pending applications·156 citations·filing 2004–2021
Top patents by PatentIndex Score
33 records- 0196US7858322B2Method of determining inhibition of binding to TRPM7 proteinNONO INC·Filed 2004·Granted Dec 28, 2010·83 cites·6 claims
- 0295US10206973B2Chloride salt of TAT-NR2B9cNONO INC·Filed 2015·Granted Feb 19, 2019·16 cites·34 claims
- 0393US11266714B2Chloride salt of TAT-NR2B9CNONO INC·Filed 2020·Granted Mar 8, 2022·2 cites·30 claims
- 0492US10251935B2Lyophilized formulation comprising tat-NR2B9C, histidine and trehaloseNONO INC·Filed 2016·Granted Apr 9, 2019·5 cites·10 claims
- 0591US9241970B2Therapy for subarachnoid hemorrhage and ischemiaNONO INC·Filed 2013·Granted Jan 26, 2016·6 cites·23 claims
- 0691US7510824B2Method of screening peptides useful in treating traumatic injury to the brain or spinal cordNONO INC·Filed 2004·Granted Mar 31, 2009·20 cites·8 claims
- 0790US10758589B2Chloride salt of TAT-NR2B9cNONO INC·Filed 2018·Granted Sep 1, 2020·3 cites·7 claims
- 0890US10300110B2Therapy for subarachnoid hemorrhage and ischemiaNONO INC·Filed 2015·Granted May 28, 2019·3 cites·1 claims
- 0989US10967041B2Combination therapy for ischemiaNONO INC·Filed 2018·Granted Apr 6, 2021·2 cites·26 claims
- 1088US10912817B2Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehaloseNONO INC·Filed 2019·Granted Feb 9, 2021·2 cites·9 claims
- 1187US10206878B2Lyophilized formulation of TAT-NR2B9C with acetylation scavengerNONO INC·Filed 2015·Granted Feb 19, 2019·5 cites·16 claims
- 1284US10046060B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2016·Granted Aug 14, 2018·3 cites·3 claims
- 1382US9610323B2Model systems and treatment regimes for treatment of neurological diseaseNONO INC·Filed 2015·Granted Apr 4, 2017·3 cites·12 claims
- 1479US11911438B2Chloride salt of TAT-NR2B9CNONO INC·Filed 2021·Granted Feb 27, 2024·0 cites·26 claims
- 1578US9433685B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2014·Granted Sep 6, 2016·2 cites·4 claims
- 1677US2020222492A1Method of Reducing Injury to Mammalian CellsNONO INC·Filed 2019·Application pending·0 cites
- 1777US2022175879A1Therapy for subarachnoid hemorrhage and ischemiaNONO INC·Filed 2021·Application pending·0 cites
- 1875US11338015B2Therapy for subarachnoid hemorrhage and ischemiaNONO INC·Filed 2019·Granted May 24, 2022·0 cites·22 claims
- 1974US11878044B2Combination therapy for ischemiaNONO INC·Filed 2021·Granted Jan 23, 2024·0 cites·20 claims
- 2073US2015190459A1Method Of Reducing Injury To Mammalian CellsNONO INC·Filed 2014·Application pending·0 cites
- 2172US8748387B2Methods for treating painNONO INC·Filed 2012·Granted Jun 10, 2014·1 cites·20 claims
- 2272US2018369319A1Method of Reducing Injury to Mammalian CellsNONO INC·Filed 2018·Application pending·0 cites
- 2370US2022096383A1Lyophilized formulation of tat-nr2b9c with acetylation scavengerNONO INC·Filed 2021·Application pending·0 cites
- 2468US2017239316A1Method Of Reducing Injury To Mammalian CellsNONO INC·Filed 2016·Application pending·0 cites
- 2562US2014323406A1Method and compositions for treating stroke with feverNONO INC·Filed 2014·Application pending·0 cites
- 2660US2019038760A1Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2018·Application pending·0 cites
- 2757US2019231693A1Lyophilized formulation of tat-nr2b9c with acetylation scavengerNONO INC·Filed 2019·Application pending·0 cites
- 2855US2023139826A1Combination treatment of stroke with plasmin-cleavable psd-95 inhibitor and reperfusionNONO INC·Filed 2021·Application pending·0 cites
- 2955US2023285504A1Inhibition of reperfusion injury with a psd-95 inhibitorNONO INC·Filed 2021·Application pending·0 cites
- 3053US2023055441A1Plasmin-resistant peptides for treating stroke and related conditionsNONO INC·Filed 2021·Application pending·0 cites
- 3150US9566284B2Agents and methods for treating ischemic and other diseasesNONO INC·Filed 2013·Granted Feb 14, 2017·0 cites·3 claims
- 3245US9073976B2ND2 peptides and methods of treating neurological diseaseNONO INC·Filed 2013·Granted Jul 7, 2015·0 cites·19 claims
- 3344US2014162957A1Lyophilized formulation of tat-nr2b9cNONO INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →